These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33588869)

  • 21. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
    MacInnis RJ; Bickerstaffe A; Apicella C; Dite GS; Dowty JG; Aujard K; Phillips KA; Weideman P; Lee A; Terry MB; Giles GG; Southey MC; Antoniou AC; Hopper JL
    Br J Cancer; 2013 Sep; 109(5):1296-301. PubMed ID: 23942072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
    Jacobi CE; de Bock GH; Siegerink B; van Asperen CJ
    Breast Cancer Res Treat; 2009 May; 115(2):381-90. PubMed ID: 18516672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
    Hung FH; Wang YA; Jian JW; Peng HP; Hsieh LL; Hung CF; Yang MM; Yang AS
    Sci Rep; 2019 Jul; 9(1):10229. PubMed ID: 31308460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.
    Mavaddat N; Ficorella L; Carver T; Lee A; Cunningham AP; Lush M; Dennis J; Tischkowitz M; Downes K; Hu D; Hahnen E; Schmutzler RK; Stockley TL; Downs GS; Zhang T; Chiarelli AM; Bojesen SE; Liu C; Chung WK; Pardo M; Feliubadaló L; Balmaña J; Simard J; Antoniou AC; Easton DF
    Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):422-427. PubMed ID: 36649146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors.
    Mabey B; Hughes E; Kucera M; Simmons T; Hullinger B; Pederson HJ; Yehia L; Eng C; Garber J; Gary M; Gordon O; Klemp JR; Mukherjee S; Vijai J; Offit K; Olopade OI; Pruthi S; Kurian A; Robson ME; Whitworth PW; Pal T; Ratzel S; Wagner S; Lanchbury JS; Taber KJ; Slavin TP; Gutin A
    Genet Med; 2024 Jul; 26(7):101128. PubMed ID: 38829299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
    Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS
    JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
    Pal Choudhury P; Wilcox AN; Brook MN; Zhang Y; Ahearn T; Orr N; Coulson P; Schoemaker MJ; Jones ME; Gail MH; Swerdlow AJ; Chatterjee N; Garcia-Closas M
    J Natl Cancer Inst; 2020 Mar; 112(3):278-285. PubMed ID: 31165158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
    Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
    JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis between the Gail, Tyrer-Cuzick and BRCAPRO Models for Breast Cancer Screening in Brazilian Population.
    Stevanato KP; Pedroso RB; Iora P; Santos LD; Pelloso FC; Melo WA; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3407-3413. PubMed ID: 31759366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
    Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
    Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.